Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Malgorzata Sieklucka"'
Autor:
Agata Surdacka, Agnieszka Bojarska-Junak, Anna Dmoszynska, Iwona Hus, Maria Luiza Kusz, Sylwia Chocholska, Malgorzata Sieklucka, Ewa Wąsik-Szczepanek, Jacek Roliński
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 98-103 (2011)
Par-4 (prostate apoptosis response-4) protein was originally found upregulated in prostate tumor cells undergoing apoptosis. Then it was further identified as a proapoptotic protein upregulated both in normal and leukemic lymphocytes. The aim of our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564d6414e672d668492ec9b0461d59eb
https://doi.org/10.5603/fhc.2011.0014
https://doi.org/10.5603/fhc.2011.0014
Autor:
Iwona Hus, Ewa Wąsik-Szczepanek, Agnieszka Bojarska-Junak, Anna Dmoszynska, Malgorzata Sieklucka, Jacek Roliński, Sylwia Chocholska
Publikováno v:
Leukemia Research. 33:1319-1327
B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f9dbd81704b0cd618b6ae7f7593510
https://doi.org/10.1016/j.leukres.2009.03.030
https://doi.org/10.1016/j.leukres.2009.03.030
Autor:
Malgorzata Sieklucka, Pawel Polak, Jacek Roliński, Ewa Wasik-Szczepanek, Agnieszka Bojarska-Junak, Anna Dmoszynska, Iwona Hus, Tomasz Mazurkiewicz
Publikováno v:
Oncology Reports. 24
The clinical significance of NK-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia (CLL) is still a subject of controversy. There are few previous descriptions that this cell population can be qualitatively or quantitatively deficient in CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ea741be7aff0e2db54dbe8426e44da
https://doi.org/10.3892/or_00000924
https://doi.org/10.3892/or_00000924
Autor:
Iwona Hus, Wioletta Trześniewska, Malgorzata Sieklucka, Ewa Wasik-Szczepanek, Magdalena Glazer, Anna Dmoszynska, Agnieszka Bojarska-Junak, Jacek Roliński
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 46, Iss 2, Pp 147-152 (2008)
Recently identified biological risk factors in B-cell chronic lymphocytic leukemia (B-CLL) include ZAP-70 and CD38 expression. The present study was conducted to clarify whether a combined analysis could improve predictive impact of these two paramet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229cb0caffdaccc5e0fb29a2dce3a0e9
https://doi.org/10.2478/v10042-008-0022-7
https://doi.org/10.2478/v10042-008-0022-7
Autor:
Iwona Hus, Michael Schmitt, Malgorzata Sieklucka, Jacek Roliński, Ewa Wąsik-Szczepanek, Agnieszka Bojarska-Junak, Monika Podhorecka, Anna Dmoszynska
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17(4)
Background: B-cell chronic lymphocytic leukaemia (B-CLL) is a disease with a highly variable clinical course; some patients never need treatment, while others require intensive treatment early after diagnosis. Recently, some new prognostic factors, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3112f4ae4819abc269cb6ef2cd3ef88c
https://pubmed.ncbi.nlm.nih.gov/16524977
https://pubmed.ncbi.nlm.nih.gov/16524977
Autor:
Malgorzata Sieklucka, Ewa Wasik-Szczepanek, Agnieszka Bojarska-Junak, Agata Surdacka, Magdalena Lewandowska, Jacek Roliński, Malgorzata Wach, Iwona Hus, Anna Dmoszynska
Publikováno v:
Blood. 112:4162-4162
B-cell chronic lymphocytic leukemia (B-CLL), is characterized by the accumulation of long-lived, neoplastic B-lymphocytes in peripheral blood, bone marrow and secondary lymphoid organs. Apoptotic processes have been shown to be altered in leukemic B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21d1af29c8c775c8cbedbb842fcc10dd
https://doi.org/10.1182/blood.v112.11.4162.4162
https://doi.org/10.1182/blood.v112.11.4162.4162
Autor:
Jacek Roliński, Anna Dmoszyńska, Sylwia Chocholska, Agata Surdacka, Maria Luiza Kusz, Ewa Wąsik-Szczepanek, Iwona Hus, Małgorzata Sieklucka, Agnieszka Bojarska-Junak
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 98-103 (2011)
Par-4 (prostate apoptosis response-4) protein was originally found upregulated in prostate tumor cells undergoing apoptosis. Then it was further identified as a proapoptotic protein upregulated both in normal and leukemic lymphocytes. The aim of our
Externí odkaz:
https://doaj.org/article/967cba0ba7f24fa3954a00b88375eda3
Autor:
Małgorzata Sieklucka, Ewa Wasik-Szczepanek, Anna Dmoszyńska, Agnieszka Bojarska-Junak, Iwona Hus, Wioletta Trześniewska, Magdalena Glazer, Jacek Roliński
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 46, Iss 2, Pp 147-152 (2008)
Recently identified biological risk factors in B-cell chronic lymphocytic leukemia (B-CLL) include ZAP-70 and CD38 expression. The present study was conducted to clarify whether a combined analysis could improve predictive impact of these two paramet
Externí odkaz:
https://doaj.org/article/8bc3d0587ec4457bbd6066726f58fabe
Autor:
Anna Dmoszynska, Jacek Roliński, Monika Podhorecka, Iwona Hus, Agnieszka Bojarska-Junak, Katarzyna Skorzynska, Malgorzata Sieklucka, Ewa Wasik-Szczepanek
Publikováno v:
Publons
ResearcherID
ResearcherID
B-CLL is a heterogeneous disease with a highly variable clinical course. The mutational status of immunoglobulin heavy-chain variable region (IgVH) genes in the leukemic cells seems to be of great importance in assessing the prognosis in B-CLL. Recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3560a3e532ee3cc3a1aed592eaf40f1e
https://publons.com/publon/11412546/
https://publons.com/publon/11412546/
Autor:
Agnieszka Bojarska-Junak, Malgorzata Sieklucka, Anna Dmoszynska, Jacek Roliński, Iwona Hus, Piotr Pozarowski
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
B-cell chronic lymphocytic leukaemia (B-CLL) has been described as the progressive accumulation of mature-appearing B cells in peripheral blood and bone marrow, resulting from failed apoptosis rather than from alterations in cell cycle regulation. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbc666bb009715abddb48681446bc57
http://www.scopus.com/inward/record.url?eid=2-s2.0-48849110623&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-48849110623&partnerID=MN8TOARS